ANXA1 and neoplasm: In the subgroup of tumor status, the median expression of ANXA1 in the metastasis ES group was significantly lower than that in the primary ES group (P=0.0072), but there was no significant difference between the primary group and recurrence group (P>0.05) (Figure 2C).